6,946 Shares in Medpace Holdings, Inc. (NASDAQ:MEDP) Purchased by Madison Investment Advisors LLC

Madison Investment Advisors LLC acquired a new position in Medpace Holdings, Inc. (NASDAQ:MEDP) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 6,946 shares of the company’s stock, valued at approximately $2,308,000.

Several other hedge funds have also recently bought and sold shares of the business. R Squared Ltd acquired a new position in Medpace in the 4th quarter worth about $30,000. SBI Securities Co. Ltd. acquired a new position in Medpace in the 4th quarter worth about $31,000. Stone House Investment Management LLC acquired a new position in Medpace in the 3rd quarter worth about $33,000. Jones Financial Companies Lllp increased its position in Medpace by 2,750.0% in the 4th quarter. Jones Financial Companies Lllp now owns 114 shares of the company’s stock worth $38,000 after purchasing an additional 110 shares during the last quarter. Finally, Lindbrook Capital LLC increased its position in Medpace by 27.6% in the 4th quarter. Lindbrook Capital LLC now owns 134 shares of the company’s stock worth $45,000 after purchasing an additional 29 shares during the last quarter. 77.98% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Separately, Robert W. Baird upped their target price on Medpace from $354.00 to $362.00 and gave the stock a “neutral” rating in a research report on Monday, January 27th. Seven investment analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. Based on data from MarketBeat, Medpace presently has a consensus rating of “Hold” and a consensus price target of $381.44.

Medpace Stock Performance

Shares of NASDAQ MEDP opened at $324.95 on Friday. The firm has a market cap of $9.90 billion, a price-to-earnings ratio of 25.73, a P/E/G ratio of 3.81 and a beta of 1.47. The business’s 50-day simple moving average is $340.28 and its 200-day simple moving average is $341.42. Medpace Holdings, Inc. has a 52 week low of $302.01 and a 52 week high of $459.77.

Medpace (NASDAQ:MEDP) last announced its earnings results on Monday, February 10th. The company reported $3.67 earnings per share for the quarter, beating the consensus estimate of $2.96 by $0.71. Medpace had a return on equity of 51.48% and a net margin of 19.17%. As a group, equities research analysts forecast that Medpace Holdings, Inc. will post 12.29 earnings per share for the current year.

About Medpace

Medpace Holdings, Inc engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance.